Cancer Vaccines
Tumor Immunotherapy
Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 2, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
1Department of Immunology, Peking University Health Science Center, Beijing, 100083, China.
Identifying cancer/testis antigens (CT antigens) is key for effective cancer vaccines. Understanding tumor-immune interactions is crucial for successful cancer immunotherapy and vaccine development.
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: